Cell Cryopreservation Market to Surpass US$ 104.8 Bn by 2035 as Cell-Based Therapies and Regenerative Medicine Fuel Industry Growth

The global cell cryopreservation market is witnessing remarkable growth as advancements in regenerative medicine, stem cell research, and cell-based therapies continue to transform modern healthcare. According to the latest industry analysis, the market was valued at US$ 14.9 Bn in 2024 and is projected to reach US$ 104.8 Bn by 2035, expanding at an impressive CAGR of 19.4% from 2025 to 2035.

Cell cryopreservation plays a vital role in preserving living cells, tissues, and biological specimens at ultra-low temperatures while maintaining their viability and functionality for future clinical and research applications. The technology has become indispensable for biobanking, regenerative medicine, personalized healthcare, gene therapy, and pharmaceutical research.

Growing investments in biotechnology, increasing adoption of advanced therapy medicinal products (ATMPs), and improvements in cryoprotectant formulations and freezing technologies are expected to create significant opportunities for market participants throughout the forecast period.

Explore the highlights and essential data from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86912

Key Drivers of Market Growth

The rising adoption of cell-based therapies is one of the strongest growth drivers for the global cell cryopreservation market. Stem cell therapies, CAR-T cell treatments, regenerative medicine, and immunotherapies require highly reliable cryogenic storage systems that preserve cell quality until clinical use.

As healthcare providers increasingly adopt personalized medicine approaches, the demand for long-term preservation of high-quality biological samples continues to accelerate. Cell cryopreservation ensures that cells retain their biological integrity, enabling their use in future therapeutic applications.

Another major growth catalyst is the rapid expansion of biobanking. Modern biobanks store millions of biological samples used in disease research, drug discovery, precision medicine, and clinical studies. The increasing establishment of national and private biobanks across developed and emerging economies is driving investments in advanced cryogenic storage infrastructure.

Furthermore, supportive regulatory initiatives by organizations such as the U.S. FDA are encouraging standardized cryopreservation practices, strengthening confidence among biotechnology companies and research institutions.

Key Players and Industry Leaders

The competitive landscape of the global cell cryopreservation market is characterized by continuous innovation, strategic partnerships, and product development.

Leading companies operating in the market include:

• Thermo Fisher Scientific Inc.
• Merck KGaA
• Sartorius AG
• BioLife Solutions Inc.
• PromoCell GmbH
• Lonza Group Ltd.
• HiMedia Laboratories
• Creative Biolabs
• Corning Incorporated
• Pluristyx Inc.
• Helmer Scientific Inc.
• Cardinal Health
• Takara Bio Inc.
• STEMCELL Technologies
• GE HealthCare

These companies are focusing on developing next-generation cryopreservation media, ultra-low temperature freezers, automated storage systems, and improved cryogenic consumables to strengthen their market position.

Key Trends for the Future

Several emerging trends are expected to redefine the future of the cell cryopreservation industry.

Automation of cryogenic storage systems is improving sample management while minimizing contamination risks. Artificial intelligence and digital monitoring technologies are also being integrated into cryogenic facilities for predictive maintenance and real-time storage monitoring.

The increasing commercialization of cell and gene therapies is expected to generate sustained demand for advanced cryopreservation solutions. Moreover, the expansion of precision medicine programs and personalized treatment protocols will further increase the need for secure long-term storage of biological materials.

Growing investments in stem cell banking and cord blood preservation are also expected to contribute significantly to market expansion.

New Opportunities and Challenges

The rapid growth of regenerative medicine presents substantial opportunities for manufacturers of cryopreservation equipment, cryoprotective agents, and storage consumables.

Emerging economies are investing heavily in biotechnology infrastructure, creating favorable conditions for expanding cryogenic storage facilities and research laboratories. Increased government funding for biomedical research and clinical trials is expected to create additional revenue opportunities.

Despite strong growth prospects, the industry faces several challenges. High installation and maintenance costs associated with ultra-low temperature freezers and liquid nitrogen storage systems remain significant barriers for smaller institutions.

Maintaining cell viability during freezing and thawing processes also requires highly standardized procedures. Continuous technological improvements are therefore essential to minimize post-thaw cell damage and maximize preservation efficiency.

Market Trends & Innovations

Innovation remains central to the evolution of the cell cryopreservation market.

Recent developments include advanced cryopreservation media that improve post-thaw recovery rates, controlled-rate freezing systems, and vitrification technologies that reduce ice crystal formation during freezing.

Manufacturers are also introducing energy-efficient ultra-low temperature freezers with improved monitoring capabilities and enhanced storage reliability.

Recent product launches further demonstrate the industry's innovation momentum:

• BioLife Solutions expanded its portfolio with advanced cryopreservation media and controlled-rate freezers.
• Thermo Fisher Scientific introduced the Thermo Scientific TSX Core Series ULT Freezers.
• Pluristyx launched PluriFreeze, a proprietary cryopreservation medium designed to improve stem cell survival after thawing.
• Colder Products Company introduced aseptic micro-connectors that simplify biological sample handling for cell and gene therapy applications.

These innovations continue to improve preservation efficiency while supporting the expanding commercialization of advanced therapies.

Buy this Premium Research Report to gain valuable industry intelligence -: https://www.transparencymarketresearch.com/checkout.php?rep_id=86912<ype=S

Future Outlook

The outlook for the global cell cryopreservation market remains highly positive through 2035.

Growing prevalence of chronic diseases, increasing clinical trials involving stem cells and immunotherapies, and continuous investments in biotechnology research are expected to sustain long-term market growth.

North America currently dominates the market, accounting for 40.2% of global revenue in 2024, supported by a strong biotechnology ecosystem, favorable regulatory policies, advanced healthcare infrastructure, and significant research funding.

Asia Pacific is expected to emerge as one of the fastest-growing regional markets due to expanding pharmaceutical manufacturing, increasing healthcare investments, and rising adoption of regenerative medicine technologies.

Market Segmentation

By Product

• Cryoprotectant Agents
• Ethylene Glycol
• Dimethyl Sulfoxide (DMSO)
• Glycerol
• Others
• Equipment
• Freezers
• Incubators
• Liquid Nitrogen Supply Tanks
• Consumables
• Cryogenic Vials
• Cryogenic Tubes
• Cooler Boxes/Containers
• Others

By Application

• Stem Cells
• Reproductive Cells
• Bioproduction Cell Lines
• Primary Cells
• Others

By End-user

• Biopharmaceutical & Pharmaceutical Companies
• Academic & Research Institutes
• Biobanks
• IVF Clinics
• Others

Important FAQs with Answers

Q1. How large was the global cell cryopreservation market in 2024?

The market was valued at US$ 14.9 Bn in 2024.

Q2. What is the projected market size by 2035?

The market is expected to reach US$ 104.8 Bn by the end of 2035.

Q3. What is the expected CAGR during the forecast period?

The market is anticipated to grow at a CAGR of 19.4% between 2025 and 2035.

Q4. What are the primary factors driving market growth?

The major growth drivers include increasing demand for cell-based therapies, expansion of biobanking, regenerative medicine advancements, and technological innovations in cryopreservation systems.

Q5. Which application segment leads the market?

The stem cells segment dominated the market with 30.7% revenue share in 2024 due to its expanding role in regenerative medicine and clinical research.

Q6. Which region dominates the global market?

North America held the largest market share of 40.2% in 2024, supported by advanced healthcare infrastructure and strong biotechnology investments.

Q7. Who are the leading companies in the market?

Major industry participants include Thermo Fisher Scientific Inc., Merck KGaA, Sartorius AG, BioLife Solutions Inc., PromoCell GmbH, Lonza Group Ltd., Corning Incorporated, STEMCELL Technologies, Takara Bio Inc., GE HealthCare, and several other prominent manufacturers.

More Related Reports –

Bone Marrow Aspirate Concentrates Market: https://www.transparencymarketresearch.com/bone-marrow-aspirate-concentrates-market.html

Antimicrobial Ingredients Market: https://www.transparencymarketresearch.com/antimicrobial-ingredients-market.html

Recombinant Proteins Market: https://www.transparencymarketresearch.com/recombinant-proteins-market.html

Oligonucleotides Market: https://www.transparencymarketresearch.com/oligonucleotides-market.html

About Us Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analyzed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

Contact:

Abhishek Budholiya

Transparency Market Research Inc.

State Tower, 90 State Street, Suite 700,

Albany NY - 12207, United States

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com

Media Inquiries: media@transparencymarketresearch.com

Sales Inquiries: sales@transparencymarketresearch.com